newsfilter
← Latest News
GlobeNewswire·

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Praxis Precision Medicines announced that on November 2, 2026, its Compensation Committee granted restricted stock unit awards covering 23,219 shares to 59 new non-executive employees.
  • The grants were made under the 2024 Inducement Plan as inducements material to employment in compliance with Nasdaq Listing Rule 5635(c)(4).
  • The 2024 Inducement Plan is used exclusively for equity awards to individuals who were not previously employed by Praxis or who had a bona fide period of non-employment.
  • The restricted stock units will vest in four equal annual installments subject to continued employment on each vesting date.